Comparison of docetaxel/cisplatin dosages of 75/60 and 60/60 mg/m(2) for the treatment of non-small cell lung cancer

A combination of docetaxel (D) and cisplatin (P) is one of the standard regimens for the initial treatment of advanced non-small cell lung cancer (NSCLC). Yet, the toxicity of D administered at 75 mg/m(2) in three weekly doses to patients is a concern. The aim of this study was to assess the efficac...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: KIM, KYU-SIK, OH, IN-JAE, BAN, HEE-JUNG, CHO, HYUN-JU, KWON, YONG-SOO, KIM, YU-IL, LIM, SUNG-CHUL, NA, KOOK-JOO, SONG, SANG-YUN, CHOI, SONG, CHOI, YOO-DUK, KIM, YOUNG-CHUL
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2012
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3460243/
https://ncbi.nlm.nih.gov/pubmed/23139720
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2012.597
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados